Gene expression profiling in women with breast cancer in a Saudi population

Saudi Medical Journal

Volumn 29, Issue 4, 2008, Pages 507-513

  Bin Amer, Suad M ^a   Maqbool, Zakia ^a   Nirmal, Maimoona S ^a   Qattan, Amal T ^a   Hussain, Syed S ^a   Jeprel, Hatim A ^a   Tulbah, Asma M ^a   Malik, Osama A ^a   Al Tweigeri, Taher A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; CYCLIN DEPENDENT KINASE 6; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN HEAVY CONSTANT GAMMA 3 PROTEIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN S9; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BREAST CANCER; CANCER TISSUE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; ONCOGENE; PATIENT CODING; POPULATION GENETICS; PROGNOSIS; RISK FACTOR; SAUDI ARABIA; BREAST TUMOR; GENE EXPRESSION; GENETICS; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAUDI ARABIA;

EID: 46749134481     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gulf Center for Cancer Registration, the Research Center; King Faisal Specialist Hospital and Research Centre. GCC: Breast Cancer in the GCC countries 1998-2002. Riyadh (Kingdom of Saudi Arabia): King Faisal Specialist Hospital and Research Centre; 2004.
2. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 (Supp 8): S4-S66.
3. Sotiriou C, Powles TJ, Dowsett M, Jazaeri A, Feldman AL, Assersohn L, et al. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res 2002; 4: 3.
4. Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, Hess K, et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy breast cancer. J Clin Oncol 2004; 22: 2284-2293.
5. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003; 100: 10393-10398.
6. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536.
7. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, et al. Gene expression profiling Breast Cancer: Understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006; 98: 262-272.
8. Wang Y, Klijn J, Zhang Y, Sieuwerts A, Look M, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365: 671-679.
9. Dumitrescu RG, Cotarla I. Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 2005; 9: 208-221.
10. Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK. Locally advanced breast cancer in Saudi Arabia: High frequency of stage III in a young population. Med Oncol 1999, 16: 95-103.
11. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006; 7: 96.
12. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
13. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 2001; 61: 5979-5984.
14. Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, et al. Tissue-wide expression profiling using cDNA subtraction and micro arrays to identify tumor-specific genes. Cancer Res 2004; 64: 844-856.
15. Iacobuzio-Donahue CA, Argani P, Hempen P, Jones J, Kern SE. The desmoplastic response to infiltrating breast carcinoma: Gene expression at the site of primary invasion and implication for comparisons between tumor types. Cancer Res 2002; 62: 5351-5357.
16. Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci 2001; 98: 10869-10874.
17. Porter D, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, et al. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res 2001; 61: 5097-5072.
18. Pierantoni G, Rinaldo C, Esposito F, Mottolese M, Soddu S, Fusco A. High mobility group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ 2006; 13: 1554-1163.
19. Belev B, Aleric I, Vrbanec D, Petrovecki M, Unusic J, Jakic-Razumovic J. Nm23 gene product expression in invasive breast cancer. Acta Oncol 2002; 41: 355-361.
20. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438: 820-827.
21. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, et al. Identification of gene expression profiles that predict the aggressive behaviour of breast cancer cells. Cancer Res 2001; 61: 5168-5178.
22. Wu Y, Zhang X, Zehner Z. c-Jun and the dominant negative mutant, TAM67, induce vimentin gene expression by interacting with the activator Sp1. Oncogene 2003; 22: 8891-8901.
23. Bukholm I, Nesland J, Bukholm G. Expression of adhesion proteins E-cadherin, alpha-catenin, beta-catenin and gamma catenin is different in T1 and T2 breast tumours. Pathology 2006; 38: 403-407.
24. Voutilainen K, Anttila M, Sillanpaa S, Ropponen K, Saarikoski S, Juhola M, et al. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. J Clin Pathol 2006; 59: 460-467.
25. Valkovic T, Dobrila F, Melato M, Sasso F, Rizzardi C, Jonjic N. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Virchows Arch 2002; 440: 583-588.
26. Bando H, Weich HA, Brokelmann M, Horiguchi S, Funata N, Ogawa T, et al. Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer. Br J Cancer 2005; 92: 553-561.
27. Donadio A, Durand S, Remedi M, Frede S, Ceschin D, Genti-Raimondi S, et al. Evaluation of stromal metalloproteinases and vascular endothelial growth factors in a spontaneous metastasis model. Exp Mol Pathol 2005; 79: 259-264.
28. Chen Q, Lin J, Jinno S, Okayama H. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation. Oncogene 2003; 22: 992-1001.
29. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Terris B, et al. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001; 20: 7437-7446.
30. Zhou YH, Hess KR, Longjian L, Linskey ME, Yung WK. Modeling prognosis for patients with malignant astrocytic gliomas: Quantifying the expression of multiple genetic markers and clinical variables. Neuro Oncol 2005; 7: 485-494.
31. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429-447.
32. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Vesculescu V, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005; 37: 899-905.
33. Selaru FN, Yin J, Olaru A, Mori Y, Xu Y, Epstein SH, et al. An unsupervised approach to identify molecular phenotypic components influencing breast cancer features. Cancer Res 2004; 64: 1584-1588.
34. Remmelink M, Mijatovic T, Gustin A, Mathieu A, Rombaut K, Kiss R, et al. Identification by means of cDNA microarray analyses of gene expression modifications in squamous non-small cell lung cancers as compared to normal bronchial epithelial tissue. Int J Oncol 2005; 26: 247-258.
35. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: Distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001; 10: 445-456.
36. Forconi F, Sahota SS, Raspadori D, Mockridge CI, Lauria F, Stevenson F. Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing. Blood 2001; 98: 1174-1181.
37. Kuroda H, Tamaru J, Takeuchi I, Ohnisi K, Sakamoto G, Adachi A, et al. Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulobular carcinoma of the breast. Virchows Arch 2006; 448: 500-505.
38. Kobielak A, Fuchs E. Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc Natl Acad Sci 2006; 103: 2322-2327.
39. Scholten AN, Aliredjo R, Creutzberg CL, Smit VT. Combined E-cadherin, ∝-catenin, and β-catenin expression is a favorable prognostic factor in endometrial carcinoma. Int J Gynecol Cancer 2006; 16: 1379-1385.
40. Bondi J, Bukholm G, Nesland J, Bakka A, Bukholm IR. An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients. Int J Colorectal Dis 2006; 21: 231-237.
41. Wu H, Li Y, Zhu G, Zhang L, Zhang X, He X. Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma. Zhonghua Yi Xue Za Zhi 2002; 82: 708-711.